Georgina Rizik is a Global Healthcare and Biotechnology Executive with over 25 years of experience across the private, public and non-profit sectors.  As the inaugural Executive Director of SC1, Georgina is leading and building the new Life Sciences Innovation District in central London, UK.  Georgina brings international commercialization expertise, with a career in Biotechnology and BioPharma that spans leadership roles in global product/portfolio strategy, lifecycle management, business development, launch planning & operations.  

Most recently, Georgina has been quite engaged in the start-up ecosystem in Canada and globally as an Advisor to Health Tech and Biotech companies.  She is Mentor (Associate) at the Creative Destruction Lab for several Health Streams and a Strategy Advisor at VoxCell BioInnovation.

Georgina is a globally minded business leader with strategic and cultural agility having worked in Canada, Switzerland, Germany and the UK with deep knowledge of the Canadian, European, US and international health care ecosystems. Experienced in leading teams, these diverse roles have fostered Georgina’s entrepreneurial and collaborative skills, generating global best practices.

Georgina holds a Bachelor of Science in Pharmacy from the University of Toronto.  In 2009, she earned her executive MBA from the Kellogg-Schulich EMBA Program (Chicago & Toronto).

Georgina is a purpose-driven leader who is passionate about transforming the global approach to the commercialization of innovation in order to drive personalized care and health equity.